Skip to main content
IB

Imagine Biotech

Imagine Biotech uses AI-driven computational modeling to de-risk drug discovery and development. Their platform provides predictive simulations for ADMET properties and molecular behavior, helping biotech companies and investors identify potential failures early and make more informed decisions.

Marina Del Rey, United StatesFounded 20238300+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Early to mid-stage biotech companies frequently encounter costly failures in drug discovery and development due to unforeseen issues like poor solubility, off-target toxicity, or inadequate drug enzyme interactions. Traditional development processes often rely on expensive, time-consuming trial-and-error experiments that lack predictive accuracy for human outcomes.

Solution

Imagine Biotech provides advanced computational modeling and AI-driven scientific due diligence to de-risk the drug discovery and development pipeline. Their platform offers predictive simulations and data analysis, enabling early insights into molecular behavior, ADMET properties, and potential toxicity. This approach helps mitigate technical risk for investors by identifying potential failures before significant capital is committed to lab studies. By providing a deeper, predictive understanding of compound behavior, Imagine Biotech facilitates faster, more informed decision-making and supports the creation of high-value intellectual property.

Target Audience

The primary customers are early to mid-stage biotech companies and investors seeking to reduce technical risk and improve decision-making in drug discovery and development.

Features

  • Predictive simulations leveraging advanced computational modeling and AI for drug discovery and development.
  • ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction with pharmacokinetic (PK) modeling.
  • Simulation of synthetic animal data using AnimalGAN.
  • Analysis of mass spectrometry data.
  • Bioinformatics and metabolite database integration.
  • 3D protein modeling and molecular docking.
  • Toxicology and drug delivery/infusion assessments.
  • Analysis of chromatography techniques.
  • Quantum chemistry calculations for molecular behavior analysis.
This profile is AI-generated and may contain inaccuracies.